Freia Pharmaceutical and Great Product Ventures Announce Joint Venture To Bring Sativa Hemp-Based Products for Cardiovascular, Dermatological, Allergological and Gynecological Treatment to the US
Cambridge, MA, United States and Milan, Italy, November 15, 2023 /EIN Newswire/— Freia Farmaceutici, S.p.A., an established, worldwide leader in developing plant-based therapeutic solutions for human health, and Great Product, a venture development firm that builds,...
BrainDTech and Great Product Ventures announce BrainCode, Inc, a US Joint Venture with the products and science capable of providing early and precise diagnostic tests for precision medicine. CAMBRIDGE, MA, USA and Milan Innovation District, Italy, For Immediate...
Great Product Ventures is very pleased to announce that it has been selected to become part of the European Commission's EU Innovation Council for the EIC Ecosystem Partnership and Co-investment Program. The European Innovation Council ( EIC ) has been...
Great Product Signs Strategic Relationship with the World’s Largest Provider of Life Sciences Regulatory Services
Great Product now offers US & EU Regulatory, Clinical and Quality Services for the Life Sciences Industry to propel EU Companies growth in the US CAMBRIDGE, MA, USA, and MILAN, ITALY, February 13, 2023/EINPresswire.com/ Great Product Ventures, Inc. the leading...
Great Product Ventures, Inc. Announces the opening of its European headquarters at MIND, Milano Innovation District, to strenghten its mission of supporting EU companies internationalization in the US market Cambridge, MA, United States and Milano, Italy, December...
Enjourney Inc.'s, Alba Robot Showcases Autonomous Vehicle Set to Revolutionize Personal Micromobility at Dubai's GITEX CAMBRIDGE, MA, USA, November 2, 2022 /EINPresswire.com/ -- Alba Robot s.r.l., part of the Joint Venture with Great Product Ventures in Enjourney Inc,...
AEBiosystems S.r.l. and Great Product Ventures, Inc. Announce a Joint Venture to Bring a Suite of Hi-Tech Patches to Remotely Monitor Vital Health Parameters to North America. Cambridge, MA, United States and Rome, Italy October 2022 /EIN Newswire/— Advanced...
FRM S.r.l., and Great Product Ventures, Inc. announce a Strategic Partnership to Bring to the US market a modular, affordable, and sustainable technology for vertical farming of bio-fortified plants for personalized nutrition Cambridge, MA, United States and Rovereto,...
TO.TEM S.r.l., spin-off of Punch Torino S.p.A., and Great Product Ventures, Inc. announce a Strategic Partnership to Bring to the US market italian designed, high-tech solutions for green micromobility Cambridge, MA, United States and Turin, Italy, TO.TEM S.r.l., a...
Bio4Dreams S.p.A. and Great Product Ventures, Inc. Announce a Strategic Partnership to Bring to the US market an outstanding portfolio of innovative companies in the Life Sciences space Cambridge, MA, United States and Milan, Italy, September 21 st , 2022 /EIN...
Creating value through commercialization
- A US entity of which you own XX% and have shared board control
- GP Partners working for you in the US
- Office location @GP’ premises in Cambridge, MA and/or Miami, FL
- Cash raised does not touch or dilute your cap table in the EU
- Significant economic impact on your EU company: higher valuations, more funds raised, boost your EU business because the US entity becomes a client.
Billion funded for EU firms in the US
Mergers & acquisitions
The true success of a company is revenue generation through commercialization. Our team is made up of senior executives who are all successful entrepreneurs in the medical, biotech and pharma sectors, with product launches that have resulted in over $500 million in sales.
With this objective in mind, we “reverse engineer” everything needed to achieve your commercial success in the US:
• Regulatory & FDA Approvals
• IP management
• Business development
• Marketing & Sales
Our retail distribution team has historically sold
over $500,000,000 of product into these retailers:
Great Product has established ”C” level relationships with key commercial organizations operating in the US and global markets.
This combination allows us to uniquely offer our clients unique value multipliers for funding and commercialization.